Xuan Cui

537 citations

24 papers · 379 indexed · h-index 12

Co-authors: Stephen H. Tsang Karen Sophia Park Ruben Jauregui Christine L. Xu Yi‐Ting Tsai Wen-Hsuan Wu Chyuan‐Sheng Lin Xiaorong Li
Topics: Retinal Development and Disorders (15 papers)Retinal Diseases and Treatments (11 papers)Photoreceptor and optogenetics research (7 papers)
Cited by: Ophthalmology Cellular and Molecular Neuroscience Molecular Biology
Journals: Proceedings of the National Academy of Sciences Journal of Clinical Investigation PLoS ONE
Partner nations: United States China Israel

In The Last Decade

Xuan Cui

22 papers receiving 374 citations

Peers

Countries citing papers authored by Xuan Cui

Since Specialization

Citations

This map shows the geographic impact of Xuan Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuan Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuan Cui more than expected).

Fields of papers citing papers by Xuan Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuan Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuan Cui. The network helps show where Xuan Cui may publish in the future.

Co-authorship network of co-authors of Xuan Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Xuan Cui. A scholar is included among the top collaborators of Xuan Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuan Cui. Xuan Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MDP25‐VDAC3 Complex Orchestrates Actin Remodeling and Mitochondrial Dynamics to Modulate Innate Immunity in Arabidopsis 2026 ·Advanced Science ·(unknown),Ping Lu,Xuan Cui,(unknown),(unknown),Jiejie Li	1
2	Integrated analysis strategies reveal the pharmacodynamic substances and action mechanisms of Huangqi San in the treatment of Alzheimer’s disease 2025 ·Journal of Pharmaceutical and Biomedical Analysis ·Ying Xu,Nan Li,Li Xu,Xuan Cui,(unknown),Mingming Li,(unknown),Fei Han	0
3	Ablating VHL in rod photoreceptors modulates RPE glycolysis and improves preclinical model of retinitis pigmentosa 2025 ·Journal of Clinical Investigation ·(unknown),Xuan Cui,(unknown),(unknown),(unknown),(unknown),Daniel T. Hass,Peter M. J. Quinn,Jianhai Du,James B. Hurley,Stephen H. Tsang	2
4	Diffusion tensor imaging in cerebral small vessel disease applications: opportunities and challenges 2024 ·Frontiers in Neuroscience ·(unknown),(unknown),Feng Wang,Xuesong He,Xuan Cui,(unknown),(unknown),Dongyan Wang	2
5	CRISPR editing of anti-anemia drug target rescues independent preclinical models of retinitis pigmentosa 2024 ·Cell Reports Medicine ·(unknown),Xuan Cui,(unknown),(unknown),(unknown),Wen-Hsuan Wu,(unknown),(unknown),Chyuan‐Sheng Lin,Daniel T. Hass,Jianhai Du,James B. Hurley,Stephen H. Tsang	8
6	Basally distributed actin array drives embryonic hypocotyl elongation during the seed‐to‐seedling transition in Arabidopsis 2023 ·New Phytologist ·Xuan Cui,Minxia Zou,Jiejie Li	7
7	HIF2α activation and mitochondrial deficit due to iron chelation cause retinal atrophy 2023 ·EMBO Molecular Medicine ·(unknown),Pei‐Kang Liu,Yao Li,(unknown),Peter M. J. Quinn,Chun‐Wei Hsu,(unknown),Jin Zhao,Xuan Cui,Ya‐Ju Chang,Katherine J. Wert,Janet R. Sparrow,Nan‐Kai Wang,Stephen H. Tsang	15
8	Renormalization of metabolic coupling treats age-related degenerative disorders: an oxidative RPE niche fuels the more glycolytic photoreceptors 2022 ·Eye ·(unknown),(unknown),Xuan Cui,Stephen H. Tsang	15
9	CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa 2022 ·Molecular Therapy ·Wen-Hsuan Wu,Yi‐Ting Tsai,I‐Wen Huang,(unknown),Chun‐Wei Hsu,Xuan Cui,(unknown),Peter M. J. Quinn,(unknown),Chyuan‐Sheng Lin,Stephen H. Tsang	23
10	Autofluorescence Imaging to Evaluate Retinal Disease Progression in Rodent 2022 ·Methods in molecular biology ·(unknown),Xuan Cui,Stephen H. Tsang	0
11	Long-term vitamin A supplementation in a preclinical mouse model forRhoD190N-associated retinitis pigmentosa 2022 ·Human Molecular Genetics ·Xuan Cui,Hye Jin Kim,(unknown),(unknown),José Ronaldo Lima de Carvalho,(unknown),(unknown),Chun‐Wei Hsu,I‐Wen Huang,Sara D. Ragi,Chyuan‐Sheng Lin,Xiaorong Li,Janet R. Sparrow,Stephen H. Tsang	10
12	PKM2 ablation enhanced retinal function and survival in a preclinical model of retinitis pigmentosa 2020 ·Mammalian Genome ·Ethan Zhang,(unknown),Sarah R. Levi,(unknown),(unknown),Xuan Cui,(unknown),Nan‐Kai Wang,José Ronaldo Lima de Carvalho,Stephen H. Tsang	12
13	CRISPR Base Editing in Induced Pluripotent Stem Cells 2019 ·Methods in molecular biology ·Ya‐Ju Chang,Christine L. Xu,Xuan Cui,Alexander G. Bassuk,Vinit B. Mahajan,Yi‐Ting Tsai,Stephen H. Tsang	12
14	Multimodal structural disease progression of retinitis pigmentosa according to mode of inheritance 2019 ·Scientific Reports ·Ruben Jauregui,(unknown),Karen Sophia Park,Xuan Cui,(unknown),José Ronaldo Lima de Carvalho,Stephen H. Tsang	29
15	Mechanisms of neurodegeneration in a preclinical autosomal dominant retinitis pigmentosa knock-in model with a RhoD190N mutation 2019 ·Cellular and Molecular Life Sciences ·Javier Sancho-Pellúz,Xuan Cui,Winston Lee,Yi‐Ting Tsai,Wen-Hsuan Wu,Sally Justus,Ilyas Washington,Chun‐Wei Hsu,Karen Sophia Park,Susanne Koch,Gabriel Velez,Alexander G. Bassuk,Vinit B. Mahajan,Chyuan‐Sheng Lin,Stephen H. Tsang	6
16	Genetic Rescue Reverses Microglial Activation in Preclinical Models of Retinitis Pigmentosa 2018 ·Molecular Therapy ·Lijuan Zhang,Xuan Cui,Ruben Jauregui,Karen Sophia Park,Sally Justus,Yi‐Ting Tsai,Jimmy Duong,Chun‐Wei Hsu,Wen-Hsuan Wu,Christine L. Xu,Chyuan‐Sheng Lin,Stephen H. Tsang	18
17	Reprogramming the metabolome rescues retinal degeneration 2018 ·Cellular and Molecular Life Sciences ·Karen Sophia Park,Christine L. Xu,Xuan Cui,Stephen H. Tsang	19
18	Clustered Regularly Interspaced Short Palindromic Repeats-Based Genome Surgery for the Treatment of Autosomal Dominant Retinitis Pigmentosa 2018 ·Ophthalmology ·Yi‐Ting Tsai,Wen-Hsuan Wu,(unknown),(unknown),Christine L. Xu,Karen Sophia Park,Xuan Cui,Sally Justus,Chyuan‐Sheng Lin,Ruben Jauregui,(unknown),Stephen H. Tsang	95
19	Multimodal characterization of a novel mutation causing vitamin B6-responsive gyrate atrophy 2018 ·Ophthalmic Genetics ·Xuan Cui,Ruben Jauregui,Karen Sophia Park,Stephen H. Tsang	13
20	Polysaccharide Hydrogel Combined with Mesenchymal Stem Cells Promotes the Healing of Corneal Alkali Burn in Rats 2015 ·PLoS ONE ·Yifeng Ke,(unknown),Xuan Cui,Yang Liu,Min Yu,Chunbo Yang,Xiaorong Li	64

About Xuan Cui

Xuan Cui is a scholar working on Ophthalmology, Aging and Cellular and Molecular Neuroscience, having authored 24 papers that have together received 379 indexed citations. Recurring topics across this work include Retinal Development and Disorders (15 papers), Retinal Diseases and Treatments (11 papers) and Photoreceptor and optogenetics research (7 papers). The work is most often cited by research in Ophthalmology (125 citations), Cellular and Molecular Neuroscience (72 citations) and Molecular Biology (266 citations). Xuan Cui has collaborated with scholars based in United States, China and Israel. Frequent co-authors include Stephen H. Tsang, Karen Sophia Park, Ruben Jauregui, Christine L. Xu, Yi‐Ting Tsai, Wen-Hsuan Wu, Chyuan‐Sheng Lin, Xiaorong Li, Sally Justus and Yifeng Ke. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact